nVerses Capital LLC Purchases 5,000 Shares of DocGo Inc. (NASDAQ:DCGO)

nVerses Capital LLC grew its position in shares of DocGo Inc. (NASDAQ:DCGO) by 151.5% in the second quarter, according to its most recent filing with the SEC. The fund owned 8,300 shares of the company’s stock after acquiring an additional 5,000 shares during the quarter. nVerses Capital LLC’s holdings in DocGo were worth $26,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Harbor Capital Advisors Inc. boosted its position in shares of DocGo by 273.4% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 396,015 shares of the company’s stock valued at $1,224,000 after acquiring an additional 289,964 shares during the last quarter. Jacobs Levy Equity Management Inc. bought a new position in shares of DocGo during the 1st quarter valued at approximately $672,000. Birchview Capital LP boosted its position in shares of DocGo by 15.4% during the 4th quarter. Birchview Capital LP now owns 150,000 shares of the company’s stock valued at $838,000 after acquiring an additional 20,000 shares during the last quarter. S Squared Technology LLC lifted its position in DocGo by 36.7% in the fourth quarter. S Squared Technology LLC now owns 1,024,438 shares of the company’s stock worth $5,727,000 after buying an additional 275,000 shares during the last quarter. Finally, Pasadena Private Wealth LLC lifted its position in DocGo by 363.6% in the first quarter. Pasadena Private Wealth LLC now owns 395,487 shares of the company’s stock worth $1,598,000 after buying an additional 310,180 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on DCGO shares. Canaccord Genuity Group lowered their price target on DocGo from $9.00 to $5.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. Cantor Fitzgerald restated an “overweight” rating and issued a $5.00 price target on shares of DocGo in a research report on Tuesday, August 20th. Needham & Company LLC restated a “buy” rating and issued a $7.00 price target on shares of DocGo in a research report on Thursday, August 8th. Finally, BTIG Research reduced their target price on DocGo from $11.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, May 9th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $6.10.

DocGo Stock Up 2.5 %

DCGO stock opened at $3.64 on Friday. The business’s fifty day simple moving average is $3.36 and its two-hundred day simple moving average is $3.42. DocGo Inc. has a twelve month low of $2.75 and a twelve month high of $7.68. The firm has a market cap of $369.70 million, a price-to-earnings ratio of 18.20, a PEG ratio of 3.22 and a beta of 0.91.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The firm had revenue of $164.95 million for the quarter, compared to analysts’ expectations of $166.61 million. DocGo had a net margin of 3.97% and a return on equity of 8.90%. Research analysts expect that DocGo Inc. will post 0.23 EPS for the current year.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.